CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 248 enrolled
Drug / intervention
Riboflavin 400mg dailydrug
Likely dose
Riboflavin 400mg dailyfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02235337
NCT02235337N/ACompleted
CompareCT.gov

The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion

University of Virginia·interventional·Posted Sep 9, 2014·Updated Aug 11, 2017

In Brief

A clinical study evaluating Riboflavin 400mg daily for Sports Related Concussion. Completed, enrolled 248 participants across 2 sites.

Detailed Summary

The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSports Related Concussion
CountriesUnited States
CollaboratorsJames Madison University

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedSep 9, 2014
Enrollment StartSep 1, 2014
Primary CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.8 years ago

Interventions

Riboflavin 400mg dailydrug